On March 23, the Institute of immunometabolism, jointly established by Shanghai Jiaotong University School of medicine and Yale University in the United States, officially launched construction. At the same time, the Joint Summit academic forum of Yale University, Medical College of Shanghai Jiaotong University, was held on the same day, focusing on the three hot frontier fields of epidemiology and health, cancer and immunotherapy, and immunometabolism.

Since then, Yale University has established its first physical research institute outside the United States in Shanghai. Richard A. Flavell, founder of the Department of immunology of Yale University, and Professor Su Bing, director of Shanghai Institute of immunology, served as the first Dean.

Richard A. Flavell: a legend in the world immunology circle, founder of the Department of immunology of Yale University, academician of the National Academy of Sciences, academician of the National Academy of medicine and academician of the Royal College of England.

Shanghai Jiaotong University School of Medicine - Yale University Institute of immunometabolism (hereinafter referred to as "the Institute") is committed to the research of immunometabolism, focusing on the regulatory mechanism and application of immune cell metabolism, expecting to make breakthroughs in key issues in the field of immunometabolism.

Immune system is the most important defense system of human body. Its regulation is closely related to tumor, infection, allergy and other diseases.

It is understood that vaccines and antibodies based on the development of immunology theory and technology have made great progress in the prevention and treatment of diseases, such as eradication of smallpox, control of poliomyelitis, leukemia and effective treatment of tumors.

Metabolism is the process of material exchange and energy exchange. It plays a certain role in a series of physiological activities such as growth, development and reproduction. Human metabolism is the metabolism of various substances with protein as the center. Once it stops, life will lose the basic conditions for survival.

Since 2018, scientists who have made major breakthroughs in the field of "tumor immunotherapy" have won the Nobel Prize in physiology or medicine, and "immunity" has attracted wide attention once. Although the field of immunometabolism generated by the intersection of immunology and metabolism has attracted the attention of many top scientific circles and laboratories, it has also been emerging since then, and it is also for effective control Major chronic diseases (such as diabetes, cancer, cardiovascular disease, aging, etc.) endangering human health have opened up a new way of prevention and treatment.

The immune system is closely related to metabolism, which is indispensable. Now it has attracted the attention of the medical circles at home and abroad. Many top scholars are also carrying out in-depth research on it, and its importance is self-evident.

Before that, sanuobio has been involved in this research field, and under the joint efforts of enterprise employees, on the premise of health, safety and environmental protection, it has successfully and efficiently produced drugs (thymopentin for injection) to assist in improving immunity. Since then, sinobio will continue to keep its original attitude, forge ahead and make due contributions to the scientific application of immunodrugs.

Warm tips: regular exercise, always keep a relaxed and happy mood, have a good work and rest habits, ensure enough sleep, also help to promote body metabolism, improve immunity.

Shengnuo bio PRODUCT

Best sales manager contact

About Shengnuo

Chengdu Shengnuo Biotechnology Co., Ltd. has "Chengdu polypeptide drug engineering technology research center" in Chengdu, mainly engaged in polypeptide, polypeptide drug and beauty peptide research. Our zero defect has passed the FDA certification, and now it has become the first-class professional peptide drug and product development, technology transfer, technical service and peptide drug industry in the scale production and export of China's parks.